PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
   
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
December 20, 2012 | ISSUE NUMBER 281 VOL 8

Special Feature
Pharma's 2012: A Review
The calendar says it's wrap-up time, not just for gifts but for some of the trends that shaped the industry — for good or bad — in the year now ending. Pharm Exec Editor-in-Chief William Looney reports ...Read more

Payer/Pharma Collaboration: A "Real World" Research Strategy for Aligning R&D to Evidence-based Healthcare
On Demand Webcast
Register Free at http://www.pharmexec.com/aligning

Regulatory
Questions About 2013's IPAB Implementation
Last week it was reported that more than 13,000 pages of rules and regulations have been issued by HHS since Nov 6th. In the midst of this massive regulatory action, certainly one of the more interesting aspects of ObamaCare's implementation is the case of the Independent Payment Advisory Board, or IPAB ...Read More

Forecast
A Glimpse of Health in 2030
Clark Herman looks at some of the predictions from the National Intelligence Council's Global Trends Report, which may play out over the next 17 years

...Read more

Pharma 2020: From vision to decision
On Demand Webcast
Register Free at http://www.pharmexec.com/decision

Legal
Compliance and Legal Not Always Eye-to-Eye
As the role and stature of the compliance officer grows, legacy senior management structures and hierarchies can accidentally pit lawyers against one another, writes Ben Comer
...Read more

Global
Saving Greek Healthcare: A Harbinger for Europe?
A new report from the European taskforce trying to help Greece crawl out of its crisis makes clear just how significant a role health reform is supposed to play in restoring health to the economy. It is, in a very acute form, a harbinger of what is around the corner for the other countries of Europe. Reflector reports
...Read more

// Amgen's CEO Robert Bradway has been named the company's Chair of the Board of Directors, replacing Kevin Sharer, who will retire at the end of the year. // Celator Pharmaceutical (Princeton, NJ) named Fred Powell as Chief Financial Officer. // AP Pharma (Redwood City, CA) appointed Joel Schaedler as Vice President, Market Access, and Daniel Martin as Vice President, Marketing.

January 24–25, 2013: 3rd Developing CAPAs in the GCP Environment Conference
Arlington, VA.


January 24–25, 2013: 5th Risk Evaluation and Mitigation Strategies Summit
Arlington, VA.


February 11–12, 2013: iPharma 2013
Philadelphia, PA.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook



Survey
Compared with 2011, has your company attended more or fewer conferences in 2012?

Click To Vote
 
Quick Links

Top Medical Innovations for 2013

ObamaCare, Innovation, and Pricing

Read the December Pharm Exec Global Digest